Docusign Inc. (NASDAQ:DOCU) Given Average Recommendation of "Hold" by Analysts

Key Points

• Docusign Inc. has received a consensus recommendation of "Hold" from nineteen analysts, with an average 1-year price objective of $94.14.
• CEO Allan C. Thygesen sold 40,000 shares of Docusign at an average price of $77.51, which represented a 21.74% decrease in his position.
• The company reported earnings per share of $0.92 for the last quarter, exceeding analysts' expectations, and showing a revenue increase of 8.8% year-over-year.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) has been given an average recommendation of "Hold" by the nineteen brokerages that are covering the firm, MarketBeat.com reports. Fourteen research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $94.1429.

A number of equities analysts recently issued reports on the stock. Zacks Research raised shares of Docusign from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, September 9th. JMP Securities restated a "market outperform" rating and issued a $124.00 target price on shares of Docusign in a research note on Friday, September 5th. Argus restated a "hold" rating on shares of Docusign in a research note on Monday, September 8th. Wall Street Zen raised Docusign from a "hold" rating to a "buy" rating in a report on Saturday, September 13th. Finally, UBS Group set a $95.00 price objective on Docusign in a report on Friday, September 5th.

Insider Activity at Docusign

In other news, Director Anna Marrs sold 728 shares of Docusign stock in a transaction on Monday, September 15th. The stock was sold at an average price of $80.30, for a total transaction of $58,458.40. Following the completion of the sale, the director owned 10,799 shares of the company's stock, valued at approximately $867,159.70. This trade represents a 6.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Robert Chatwani sold 13,817 shares of the business's stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total value of $1,148,192.70. Following the sale, the insider owned 71,162 shares in the company, valued at approximately $5,913,562.20. This trade represents a 16.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 82,533 shares of company stock valued at $6,598,028. 1.01% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Janus Henderson Group PLC increased its position in shares of Docusign by 13.1% during the 4th quarter. Janus Henderson Group PLC now owns 13,691 shares of the company's stock valued at $1,231,000 after purchasing an additional 1,581 shares during the last quarter. ProShare Advisors LLC bought a new stake in shares of Docusign in the fourth quarter worth $886,000. Rafferty Asset Management LLC grew its holdings in shares of Docusign by 33.8% in the fourth quarter. Rafferty Asset Management LLC now owns 27,594 shares of the company's stock worth $2,482,000 after acquiring an additional 6,967 shares during the period. Snowden Capital Advisors LLC bought a new stake in Docusign during the fourth quarter valued at about $546,000. Finally, Toronto Dominion Bank grew its holdings in Docusign by 1.3% during the fourth quarter. Toronto Dominion Bank now owns 26,508 shares of the company's stock valued at $2,384,000 after purchasing an additional 349 shares during the period. Hedge funds and other institutional investors own 77.64% of the company's stock.

Docusign Trading Down 0.5%

DOCU traded down $0.42 on Wednesday, reaching $84.59. The company had a trading volume of 4,516,106 shares, compared to its average volume of 3,404,911. Docusign has a one year low of $57.58 and a one year high of $107.86. The company has a fifty day moving average of $76.39 and a 200-day moving average of $79.30. The company has a market capitalization of $17.01 billion, a P/E ratio of 63.60, a PEG ratio of 4.46 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.84 by $0.08. The company had revenue of $800.64 million during the quarter, compared to analysts' expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business's revenue for the quarter was up 8.8% on a year-over-year basis. During the same period last year, the company posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Research analysts predict that Docusign will post 1.17 EPS for the current year.

Docusign announced that its board has approved a stock repurchase plan on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 6.6% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's management believes its stock is undervalued.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.